blog posts

• Hergenrother named a 2023 National Cancer Institute Outstanding Investigator

  Jan 16, 2024 2:30 pm by Jonathan KingExcellence
  • Share on Facebook
  • Tweet
  • Email

  

  Images

  • 

  Paul Hergenrother’s lab has discovered multiple new anticancer compounds, including PAC-1, which  recently completed a Phase 1 clinical trial in late-stage cancer patients. 

  stats

  additional actions
  • Share on Facebook
  • Tweet
  • Email